Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.
about
N-Linked Glycosylation Status of Classical Swine Fever Virus Strain Brescia E2 Glycoprotein Influences Virulence in SwineStructure and Mutagenesis of the Parainfluenza Virus 5 Hemagglutinin-Neuraminidase Stalk Domain Reveals a Four-Helix Bundle and the Role of the Stalk in Fusion PromotionEvolution of the receptor binding properties of the influenza A(H3N2) hemagglutininReceptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virusStructure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutininsInfection of human airway epithelium by human and avian strains of influenza a virus.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Expansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in China.Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence.Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein DNovel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United StatesRecombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex.Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemicGlycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulenceThe T160A hemagglutinin substitution affects not only receptor binding property but also transmissibility of H5N1 clade 2.3.4 avian influenza virus in guinea pigs.Evolutionary characterization of human H1N1 influenza virus hemagglutinin genes isolated from 1947 to 2009 in China.High mannose-binding lectin with preference for the cluster of alpha1-2-mannose from the green alga Boodlea coacta is a potent entry inhibitor of HIV-1 and influenza viruses.Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10.Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1/2009 influenza A virus in miceN-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.Changing selective pressure during antigenic changes in human influenza H3.Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.The Length of N-Glycans of Recombinant H5N1 Hemagglutinin Influences the Oligomerization and Immunogenicity of Vaccine AntigenRespiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea.Antigenic variation of clade 2.1 H5N1 virus is determined by a few amino acid substitutions immediately adjacent to the receptor binding site.Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan.Glycosylation site alteration in the evolution of influenza A (H1N1) viruses.Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin.Prediction of biological functions on glycosylation site migrations in human influenza H1N1 virusesConfident assignment of site-specific glycosylation in complex glycoproteins in a single stepAddition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion.Compensatory evolution of net-charge in influenza A virus hemagglutinin.Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture.Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodiesComparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms.
P2860
Q27478046-0C6D3E9E-9087-425F-9FA7-4B3132E47A5BQ27674994-2537CDE0-2D86-4312-8105-6B6F4821CE39Q27675474-F7B99A97-D514-49BB-9202-884E49E1E04AQ27683156-0C0EB84D-762A-4471-B8A2-03C015DC96F9Q27697647-715064B2-5650-4C46-859F-D897EB573F18Q30355972-317B9D41-C247-43A6-827D-23598F71AFC2Q30358388-B5525262-2F8A-444E-B8A0-A45BE9BFAAF5Q30360290-F3DA27A5-07B9-4E84-B200-4A9610555279Q30364522-DEDC50BA-E434-46F3-9E9A-62DC4AD02240Q30365296-474BC685-E2FB-4314-90A9-EDAF4D631610Q30370987-EF223B5D-3B59-4B46-9BF1-881266F9971CQ30372223-A79588B9-1195-472D-9105-1AB29CF62D57Q30378432-1D7F5444-3A69-4632-BE34-B88A11A5D425Q30382876-EAF66D2C-335F-4E2F-B7E0-7EEB1EEAADABQ30387829-397524F0-6A70-4C56-B177-11DAAD076976Q30391639-2B9077F3-DB92-45FA-9EC2-2FFA57F39E44Q30394678-AB2D71FE-7990-4AFF-9377-D02336F244DDQ30398273-5CAA04C6-AD2D-4F71-9CCC-2C5554B03B65Q30399343-38CD5785-E45E-4658-A543-D413F734A868Q30401412-85823046-F81F-4D59-B748-2D2853BD9309Q30412988-9D8E2137-1299-41C7-8EE1-3C5C74A64AC4Q30419865-FCDD6798-02B8-4CD2-B428-AA5563E70B3AQ30430049-99D33D12-1DB3-4711-9CFA-7E41E3AAA760Q30431513-4B66FEFF-031B-4BE8-914D-A47FA5286900Q33331398-8F29AA9E-A0DC-48CA-B78B-8A08A9DD9F2AQ33520040-B2252106-624C-41F3-A83D-BFCF7AE02D45Q33580863-FDD15BDE-3D24-4D73-8ED0-DBB418F0CEBDQ33591243-8A375714-BF79-4385-BD28-D5328A824D99Q33729955-77618658-46F3-48DA-BA78-47E750F15E52Q33751834-8A897F25-583F-4118-8B3F-9408F76D96F6Q33753268-B1737E25-422A-4BEA-A365-E17F25373A79Q33987971-94489621-647B-4779-922E-9F27828F0C7AQ34098121-A6087E0C-0057-4618-AB17-95D94B398A00Q34166548-2DEF9223-43B3-4CC0-880F-94A46E9EAB12Q34286011-271CFA0C-A7AD-4634-8772-488FFFAE4C8DQ34301817-2E8E7B1F-691D-4602-AB40-75794016BCADQ34342017-49823B62-DDEB-4A9F-B26E-F8EBD89B839FQ34538848-BCFB4492-60D7-4F8E-995C-F51BF713EFF1Q34545996-E7B12AE0-BFEA-485C-B4A1-BD0103224350Q34814833-868C8654-EF7A-4B1B-93A3-3266D6554258
P2860
Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@en
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@nl
type
label
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@en
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@nl
prefLabel
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@en
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@nl
P2093
P2860
P1433
P1476
Effect of the addition of olig ...... za A/H3N2 virus hemagglutinin.
@en
P2093
Emi Takashita
Kanetsu Sugawara
Seiji Hongo
Yasuhiro Abe
Yasushi Muraki
Yoko Matsuzaki
P2860
P304
P356
10.1128/JVI.78.18.9605-9611.2004
P407
P577
2004-09-01T00:00:00Z